Tissue Engineered Models of Brain Tumors and Their Applications
75
medicine, mathematical modeling, dissecting the cellular and molecular na-
ture of the tumor for basic research are keys to address challenges to find a
cure.
Since diversity and changes in cellular and extracellular environments are
primary mediators between pre-clinical tissue engineering models and clinical
trials for brain tumors, GBM microenvironment will be highlighted to under-
stand the sources and contribution of cellular and molecular heterogeneity in
this chapter. Non-cellular components of this 3D network will also be summa-
rized, as they are key players to develop innovative in vitro mimics of tumor
tissue. A detailed analysis will further be performed on GBM models in tissue
engineering with their current applications.
3.2
Glioblastoma (GBM) Microenvironment
In GBM, tumor and its growth are not isolated, as they include a complex
interplay between cellular and non-cellular components contributed by signif-
icant changes in tissue organization, interactions and signaling. This environ-
ment is assembled with cancer cells and cancer stem cells, tissue resident cells,
infiltrating immune system cells and vasculature. Besides, non-cellular compo-
nents are crucial, as they play a pivotal role in tumor progression and therapy.
Thus, our current understanding of this crosstalk is of utmost importance to
the onset, progression and prognosis of GBM as well as is a key hallmark to
establish diverse treatment and tissue-engineered model strategies to improve
clinical outcomes. This 3D non-cellular network of tumor environment is built
with extracellular matrix (ECM), soluble signals and their gradients [3, 4]. In
this section, an overview of these cellular and non-cellular constituents of GBM
microenvironment, as well as their essential tasks for tumor and tumor-model
reconstruction will be provided.
3.2.1
Cellular Environment and Signals of GBM
GBM onset and progression modify the content of the relevant brain tissue in
a unique pattern. In this tumor, cancer cells, cancer stem cells, tissue-resident
cells, resident and migrating immune system cells, and brain vasculature are
the major cells/cell sources in tumor mass or in the surrounding tissue. Ad-
ditionally, interface between brain and blood circulation is built with blood-
brain barrier (BBB) that contributes to both healthy brains as well as the
development of related diseases [3, 4].
3.2.1.1
Cancer Cells, Cancer Stem Cells (CSCs)
Currently, cell of origin for GBM is largely unknown, but it has been con-
sidered that neural stem cells, astrocytes, oligodendrocyte precursor cells and